<DOC>
	<DOCNO>NCT02816853</DOCNO>
	<brief_summary>The purpose study assess effect domperidone QTc interval duration Chinese healthy adult participant multiple domperidone dose 10 milligram ( mg ) 3 time day ( tid ) 20 mg tid .</brief_summary>
	<brief_title>Study Evaluate Effects Domperidone Cardiac Repolarization Chinese Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Participant must healthy basis physical examination , medical history , vital sign , 12lead electrocardiogram ( ECG ) perform Screening . If abnormality , must consistent underlie illness study population . This determination must record participant source document sign investigator Participant must healthy basis clinical laboratory test perform Screening . If result serum chemistry panel include liver enzyme , hematology , urinalysis outside normal reference range , participant may include investigator judge abnormalities deviation normal clinically significant appropriate reasonable population study . This determination must record participant source document sign investigator A woman , must prove nonpregnant via highly sensitive serum betahuman chorionic gonadotropin ( betahCG ) pregnancy test Screening ; negative urine pregnancy test Day 1 treatment period Due lack adequate reproductive toxicity data , addition user independent highly effective method contraception , male female condom without spermicide require . Male condom female condom use together ( due risk failure friction ) Body mass index ( BMI ; weight [ kilogram { kg } ] /height^2 [ meter { } ] ^2 ) 18 30 kilogram per meter square [ kg/m^2 ] ( inclusive ) , body weight less 50 kilogram ( kg ) History current clinically significant medical illness include cardiac arrhythmia cardiac disease , hematologic disease , coagulation disorder ( include abnormal bleeding blood dyscrasia ) , lipid abnormality , significant pulmonary disease , include bronchospastic respiratory disease , diabetes mellitus , renal hepatic insufficiency , thyroid disease , neurologic psychiatric disease , infection , gastrointestinal disease , illness investigator considers exclude participant could interfere interpretation study result Clinically significant abnormal value hematology , clinical chemistry urinalysis screen admission study center deem appropriate investigator Presence hyperkalemia , hypokalemia , hypermagnesemia , hypomagnesemia , hypercalcemia hypocalcemia Clinically significant abnormal physical examination , vital sign 12Lead electrocardiogram ( ECG ) Screening admission study center deem appropriate investigator Known allergy Domperidone excipients formulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>